Clinical Trial Update: A Phase II Study of Nasal NK/T-cell Lymphoma [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II study targeting nasal-type extranodal NK/T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Lymphoma | Phase 2 | Status: COMPLETED